Efficacy of Bamlanivimab in Reducing Hospitalization and Mortality Rates in COVID-19 Patients in a Rural Community

Objective In this study, we aimed to evaluate the association between the monoclonal antibody infusion, bamlanivimab, and a reduction in 30-day hospitalization and mortality rates in patients with coronavirus disease 2019 (COVID-19) in a rural community setting with various comorbidities. Methodolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Leena, Terlau, Thomas J, Hernandez, Alexander, Woods, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372678/
https://www.ncbi.nlm.nih.gov/pubmed/34430093
http://dx.doi.org/10.7759/cureus.16477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372678/
https://www.ncbi.nlm.nih.gov/pubmed/34430093
http://dx.doi.org/10.7759/cureus.16477

Ejemplares similares